LUT014 works by paradoxically reactivating MAPK, a key signaling pathway in the skin that anti-EGFR therapies shut down.

Thermo Fisher Scientific and Danaher are projecting that their sales to academic and government (A&G) customers will shrink ...

University of Pittsburgh scientists working with UPMC infection preventionists have developed an infectious diseases detection platform that, over a two-year trial, was found to stop outbreaks, save ...

AACR conference chairs Lillian L. Siu, MD, and Matthew Vander Heiden, MD, PhD, share their perspectives on the event with GEN ...

Removing EPO signaling in mouse liver tumors leads to tumor regression along with sensitivity to immunotherapy.

FUJIFILM has invested about $4 billion in building biopharmaceutical manufacturing sites and life sciences capabilities.

Scientists can build microfluidic systems in a Petri dish out of collagen, cells, and other proteins with structural ...

Researchers show that glycoRNAs, uncovered by the lab of Nobel Laureate, Carolyn Bertozzi, can be used to fight cancer.

Removing EPO signaling in mouse liver tumors leads to tumor regression along with sensitivity to immunotherapy.

Revvity and Watchmaker Genomics are working to bring more flexible and scalable NGS solutions to researchers worldwide.

The agreement allows EditCo to integrate Promega's HiBiT, HaloTag, and NanoLuc protein tagging tech with its knock-in gene ...

Siren said proceeds will go toward investigational new drug (IND)-enabling animal studies and clinical-grade production of ...